Oxidized low-density lipoprotein (ox-LDL) is known to trigger vascular injury in atherosclerosis development. Sodium ferulate is an effective component from Chinese medicines with various beneficial cardiovascular pharmacological activities. Here, we investigated the effects of sodium ferulate on the gene expression profile of ox-LDL-stimulated endothelial cells. Cultured human umbilical vein endothelial cells (HUVECs) were treated with ox-LDL (50 μg/mL) in the absence or presence of sodium ferulate (5 μmol/L). Sodium ferulate significantly reduced ox-LDL-induced endothelial cell death as evaluated by cell viability assay. Human oligonucleotide microarray analysis demonstrated that a total of 32 ox-LDL-induced genes were significantly downregulated to control levels by sodium ferulate. These genes included members from families of chemokine, inflammatory factor, growth factor, and nuclear receptor. These data provided an overview of the gene expression profile of endothelial cells in response to ox-LDL and sodium ferulate, and demonstrated that sodium ferulate could regulate the expression of inflammation-related genes in endothelial cells and has the potential to benefit endothelial function in the setting of atherosclerosis.
Ross R.The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362(6423):801-809.
2.
Chen YH, Lin SJ, Ku HH, Lin FY, Chen JW, Chen YLSalvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J Cell Biochem. 2001;82(3):512-521.
3.
Cushing SD, Berliner JA, Valente AJ, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A. 1990; 87(13):5134-5138.
Ermak N., Lacour B., Drueke TB, Vicca S.Role of reactive oxygen species and Bax in oxidized low density lipoprotein-induced apoptosis of human monocytes. Atherosclerosis. 2008;200(2):247-256.
6.
Li D., Mehta JLUpregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol. 2000;20(4):1116-1122.
7.
Liu SF, Malik ABNF-kappa B.activation as a pathological mechanism of septic shock and inflammation . Am J Physiol Lung Cell Mol Physiol. 2006 ;290(4):L622-L645.
8.
Valen G., Yan ZQ, Hansson GKNuclear factor kappa-B and the heart. J Am Coll Cardiol . 2001;38(2):307-314.
9.
Wang BH, Ou-Yang JPPharmacological actions of sodium ferulate in cardiovascular system . Cardiovasc Drug Rev. 2005;23(2):161-172.
10.
Srinivasan M., Sudheer AR, Menon VPFerulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr. 2007;40(2):92-100.
11.
Graf E.Antioxidant potential of ferulic acid. Free Radic Biol Med . 1992;13(2):435-448.
12.
Masuda T., Yamada K., Maekawa T., Takeda Y., Yamaguchi H.Antioxidant mechanism studies on ferulic acid: identification of oxidative coupling products from methyl ferulate and linoleate. J Agric Food Chem. 2006;54(16):6069-6074.
13.
Ogiwara T., Satoh K., Kadoma Y., et al. Radical scavenging activity and cytotoxicity of ferulic acid . Anticancer Res. 2002;22(5):2711-2717.
14.
Fernandez MA , Saenz MT, Garcia MDAntiinflammatory activity in rats and mice of phenolic acids isolated from. Scrophularia frutescens. J Pharm Pharmacol. 1998;50(10):1183-1186.
15.
Wang B., Ouyang J., Liu Y., et al. Sodium ferulate inhibits atherosclerogenesis in hyperlipidemia rabbits. J Cardiovasc Pharmacol. 2004;43(4):549-554.
16.
Sehested M. , Hou-Jensen K. Factor VII related antigen as an endothelial cell marker in benign and malignant diseases. Virchows Arch A Pathol Anat Histol. 1981; 391(2):217-225.
17.
Cominacini L. , Pasini AF, Garbin U., et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000 ;275(17):12633-12638.
18.
Xiaohong Y. , Jing-Ping OY, Shuzheng T.Angelica protects the human vascular endothelial cell from the effects of oxidized low-density lipoprotein in vitro. Clin Hemorheol Microcirc. 2000 ;22(4):317-323.
19.
Havel RJ, Eder HA, Bragdon JHThe distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955; 34(9):1345-1353.
20.
Cominacini L., Garbin U., Davoli A., et al. A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J Lipid Res . 1991;32(2):349-358.
21.
Guo Y., Guo H., Zhang L., et al. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J Virol. 2005;79(22):14392-14403.
22.
Patterson TA , Lobenhofer EK, Fulmer-Smentek SB, et al. Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nat Biotechnol. 2006 ;24(9): 1140-1150.
23.
Smith L., Underhill P., Pritchard C., et al. Single primer amplification (SPA) of cDNA for microarray expression analysis. Nucleic Acids Res. 2003;31(3):e9.
24.
Yang YH, Dudoit S., Luu P., et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002;30(4):e15.
25.
Sun YM, Zhang Y., Zeng LQ, et al. Broad profiling of DNA-binding transcription factor activities improves regulatory network construction in adult mouse tissues. J Proteome Res. 2008;7(10):4455-4464.
26.
Pfaffl MWA new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.
27.
Tichopad A. , Dilger M., Schwarz G., Pfaffl MWStandardized determination of real-time PCR efficiency from a single reaction set-up. Nucleic Acids Res . 2003;31(20):e122.
28.
Chua MS, Sarwal MMMicroarrays: new tools for transplantation research. Pediatr Nephrol. 2003;18(4): 319-327.
29.
Stocker R.The ambivalence of vitamin E in atherogenesis. Trends Biochem Sci. 1999;24(6):219-223.
30.
Upston JM, Kritharides L., Stocker R.The role of vitamin E in atherosclerosis. Prog Lipid Res. 2003;42(5):405-422.
31.
de Boer OJ, van der Wal AC, Becker AEAtherosclerosis, inflammation, and infection. J Pathol . 2000;190(3): 237-243.
32.
Memon RA, Staprans I., Noor M., et al. Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol. 2000;20(6):1536-1542.
33.
Libby P.Inflammation in atherosclerosis. Nature. 2002 ;420(6917):868-874.
34.
Kuziel WA, Morgan SJ, Dawson TC, et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A. 1997;94(22):12053-12058.
35.
Zlotnik A., Yoshie O.Chemokines: a new classification system and their role in immunity . Immunity. 2000; 12(2):121-127.
36.
Sun J., Sukhova GK, Wolters PJ, et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med. 2007;13(6):719-724.
37.
Tedgui A., Mallat Z.Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006; 86(2):515-581.
38.
Krishnaswamy G., Kelley J., Yerra L., Smith JK, Chi DSHuman endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res. 1999;19(2):91-104.
39.
Bonta PI, van Tiel CM, Vos M., et al. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol. 2006;26(10):2288-2294.
40.
Martinez-Gonzalez J., Badimon L.The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. Cardiovasc Res. 2005;65(3):609-618.
